The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis.
Hofbauer
L C
LC
Division of Gastroenterology, Endocrinology, and Metabolism, Zentrum für Innere Medizin, Philipps University, Marburg, Germany.
Heufelder
A E
AE
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000209:etiology* / Q000628:therapy*; D006023:Glycoproteins / Q000502:physiology*; D006801:Humans; D008024:Ligands; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology*; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology
D006023:Glycoproteins; D008024:Ligands; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human